Summary: An amended financial disclosure dated April 17 shows that Kevin Warsh, the nominee to lead the Federal Reserve, has pledged to divest his stake in the iShares S&P/TSX 60 Index (XIU) if he is confirmed. Fed ethics officials advised that his responsibilities would involve particular matters affecting the underlying holdings of that Canadian equity fund, prompting the commitment to sell.
In the amended filing, Warsh informed the Fed's internal ethics officer that he will dispose of his interest in the XIU fund. The iShares S&P/TSX 60 Index targets Canadian equities, and agency ethics personnel determined Warsh's role would entail engagement with matters that relate specifically to the fund's underlying financial interests.
Federal Reserve rules place restrictions on what investments policymakers and their immediate family members may retain. Those rules include limits on exposure to foreign investments and prohibitions on certain types of holdings. The amended disclosure was filed following Warsh's initial submission on April 10, and it supplements the broader set of financial information released last week.
That earlier disclosure showed Warsh holds a broad portfolio of investments, many of which the filing indicated are not fully disclosed and which he said he would need to divest if confirmed to the Fed's top post. The April 17 amendment narrows that focus by identifying a specific fund - XIU - that he will sell following the ethics review.
Warsh, a financier and former Fed governor, is scheduled to appear for a confirmation hearing on Tuesday before the Senate Banking Committee. The path to confirmation faces obstacles: a legal investigation involving the Federal Reserve and its current leadership has prompted several legislators to state that they will withhold support for Warsh's confirmation until the inquiry is resolved. Those positions reduce the likelihood that he will assume the Fed chair role when the current chair's tenure ends on May 15.
The Fed's internal ethics officer stated in the latest filing that Warsh is in compliance with the applicable laws and regulations that govern conflicts of interest. The filing and the ethics officer's note together indicate that the commitment to divest XIU is intended to align Warsh's financial holdings with the conflict-of-interest standards expected of a Fed chair.
Key points
- Warsh has pledged to sell his stake in iShares S&P/TSX 60 Index (XIU) if confirmed, following an amended financial disclosure dated April 17.
- The Fed's ethics review concluded his duties would involve particular matters affecting the underlying holdings of the Canadian equity fund, prompting the divestiture commitment.
- The nomination process is complicated by a separate legal investigation into the Fed's leadership and related legislative objections, which may delay or prevent a confirmation before the current chair's term ends on May 15.
Risks and uncertainties
- Political and procedural risk - The ongoing legal investigation into the Federal Reserve and objections from some legislators create uncertainty about whether Warsh will be confirmed in time to replace the current chair on May 15. This uncertainty affects governance continuity at the central bank.
- Portfolio adjustment risk - Warsh has indicated he holds a wide range of investments, many not fully disclosed in the filings; these holdings would need to be sold if he assumes the chair position, introducing potential short-term market impacts related to divestitures of his assets.
- Regulatory compliance risk - While the Fed's internal ethics officer found Warsh in compliance with applicable conflict-of-interest laws and regulations, additional disclosures or later determinations could alter that assessment.
Note: The article reflects information contained in Warsh's amended and original financial disclosures and statements noted in the filings. It does not add facts beyond what those documents and the disclosure statements specify.